Biogen Inc. (NASDAQ:BIIB) Shares Sold by Fifth Third Bancorp - Defense World

Retrieved on: 2024-01-21 17:42:06

Tags for this article:

Spinal muscular atrophy

Biogen

Interferon beta-1a

Aducanumab

Fifth Third Bancorp

Click the tags to see associated articles and topics

Biogen Inc. (NASDAQ:BIIB) Shares Sold by Fifth Third Bancorp - Defense World. View article details on hiswai:

Summary

The article discusses Fifth Third Bancorp's reduced investment in Biogen, a biotechnology firm involved in capital markets, with key drugs like Aducanumab and treatments for conditions like spinal muscular atrophy. It also details Biogen's financials and stock analyst growth forecasts.

Article found on: www.defenseworld.net

View Original Article